Deutsche Bank
STOK icon

Deutsche Bank’s Stoke Therapeutics STOK Stock Holding History

Deutsche Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
57,784
+17,188
+42% +$552K ﹤0.01% 1939
2026
Q1 		$1.32M Buy
40,596
+7,190
+22% +$236K ﹤0.01% 2022
2025
Q4 		$1.06M Buy
33,406
+9,176
+38% +$276K ﹤0.01% 2161
2025
Q3 		$569K Buy
24,230
+3,927
+19% +$67.3K ﹤0.01% 2481
2025
Q2 		$230K Sell
20,303
-5,263
-21% -$50K ﹤0.01% 2881
2025
Q1 		$170K Sell
25,566
-325,048
-93% -$3.03M ﹤0.01% 3028
2024
Q4 		$3.87M Sell
350,614
-111,861
-24% -$1.37M ﹤0.01% 1463
2024
Q3 		$5.68M Buy
462,475
+446,445
+2,785% +$6.32M ﹤0.01% 1231
2024
Q2 		$217K Sell
16,030
-396,210
-96% -$5.35M ﹤0.01% 2762
2024
Q1 		$5.57M Sell
412,240
-538
-0.1% -$3.26K ﹤0.01% 1224
2023
Q4 		$2.17M Buy
412,778
+399,016
+2,899% +$1.71M ﹤0.01% 1637
2023
Q3 		$54.2K Sell
13,762
-556,749
-98% -$3.66M ﹤0.01% 3393
2023
Q2 		$6.06M Sell
570,511
-146,406
-20% -$1.56M ﹤0.01% 1173
2023
Q1 		$5.97M Sell
716,917
-30,869
-4% -$278K ﹤0.01% 1165
2022
Q4 		$6.9M Sell
747,786
-39,099
-5% -$407K ﹤0.01% 1106
2022
Q3 		$10.1M Sell
786,885
-1,496
-0.2% -$23.8K 0.01% 952
2022
Q2 		$10.4M Buy
788,381
+516,495
+190% +$7.85M 0.01% 981
2022
Q1 		$5.72M Buy
271,886
+247,555
+1,017% +$4.96M ﹤0.01% 1356
2021
Q4 		$584K Sell
24,331
-2,864
-11% -$68.3K ﹤0.01% 2736
2021
Q3 		$693K Buy
27,195
+14,628
+116% +$408K ﹤0.01% 2846
2021
Q2 		$423K Buy
12,567
+3,499
+39% +$124K ﹤0.01% 3329
2021
Q1 		$352K Sell
9,068
-141
-2% -$8.03K ﹤0.01% 3322
2020
Q4 		$570K Buy
9,209
+2,474
+37% +$113K ﹤0.01% 2824
2020
Q3 		$225K Buy
6,735
+590
+10% +$16.8K ﹤0.01% 3155
2020
Q2 		$146K Buy
6,145
+235
+4% +$5.58K ﹤0.01% 3272
2020
Q1 		$135K Buy
5,910
+2,659
+82% +$65.7K ﹤0.01% 3129
2019
Q4 		$91K Buy
3,251
+426
+15% +$10.7K ﹤0.01% 3631
2019
Q3 		$59K Buy
+2,825
New +$78.8K ﹤0.01% 3839

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank's STOK Position: Q2 2026 in Review

Deutsche Bank increased its Stoke Therapeutics (STOK) stake by 42% in Q2 2026, buying an estimated $552K and bringing the position to 57,784 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Deutsche Bank first reported a position in STOK in Q3 2019 and has held it in 28 quarters since. The position peaked at $10.4M in Q2 2022. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Deutsche Bank held 57,784 shares of Stoke Therapeutics worth $1.89M as of Q2 2026.
  • Deutsche Bank bought 17,188 Stoke Therapeutics shares in Q2 2026, an estimated $552K.
  • Stoke Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1939 holding.
  • Deutsche Bank first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • Deutsche Bank's Stoke Therapeutics position peaked at $10.4M in Q2 2022.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.